Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
Public ClinicalTrials.gov record NCT02355665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study Using a Naturalistic Clinical Model to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers Motivated to Quit
Study identification
- NCT ID
- NCT02355665
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
- Industry
- Enrollment
- 1,198 participants
Conditions and interventions
Conditions
Interventions
- Nicotine Spray Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2015
- Primary completion
- Sep 29, 2015
- Completion
- Feb 9, 2016
- Last update posted
- Jan 7, 2019
2015 – 2016
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| Los Angeles Clinical Trials | Burbank | California | 91505 | — |
| Radiant Research, Inc | Chicago | Illinois | 60654 | — |
| University of Maryland | College Park | Maryland | 20742 | — |
| Radiant Research, Inc. | Akron | Ohio | 44311 | — |
| Radiant Research | Cincinnati | Ohio | 45249 | — |
| Radiant Research, Inc | Dallas | Texas | 75231 | — |
| Radiant Research, Inc | Salt Lake City | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02355665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02355665 live on ClinicalTrials.gov.